CVS Health
About: CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the us. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It also operates a top-tier health insurer (acquired through Aetna) where it serves about 26 million medical members. The company's recent acquisition of Oak Street adds primary care services to the mix, which could have significant synergies with all its existing business lines.
Employees: 300,000
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
23% more call options, than puts
Call options by funds: $1.7B | Put options by funds: $1.38B
2.42% more ownership
Funds ownership: 80.77% [Q3] → 83.2% (+2.42%) [Q4]
11% less funds holding
Funds holding: 1,808 [Q3] → 1,613 (-195) [Q4]
26% less capital invested
Capital invested by funds: $63.8B [Q3] → $47.1B (-$16.7B) [Q4]
41% less first-time investments, than exits
New positions opened: 214 | Existing positions closed: 362
52% less funds holding in top 10
Funds holding in top 10: 27 [Q3] → 13 (-14) [Q4]
61% less repeat investments, than reductions
Existing positions increased: 356 | Existing positions reduced: 911
Research analyst outlook
6 Wall Street Analysts provided 1 year price targets over the past 3 months
6 analyst ratings
JP Morgan Lisa Gill 64% 1-year accuracy 14 / 22 met price target | 25%upside $81 | Overweight Maintained | 18 Feb 2025 |
Wells Fargo Stephen Baxter 25% 1-year accuracy 10 / 40 met price target | 12%upside $73 | Overweight Maintained | 13 Feb 2025 |
Truist Securities David Macdonald 59% 1-year accuracy 55 / 94 met price target | 17%upside $76 | Buy Maintained | 13 Feb 2025 |
Barclays Andrew Mok 34% 1-year accuracy 20 / 58 met price target | 12%upside $73 | Overweight Maintained | 13 Feb 2025 |
Leerink Partners Michael Cherny 71% 1-year accuracy 20 / 28 met price target | 15%upside $75 | Outperform Upgraded | 13 Feb 2025 |
Financial journalist opinion
Based on 59 articles about CVS published over the past 30 days









